Latest Health News

Alcidion has secured regulatory approval for its AI-powered clinical tool in Australia and the UK, paving the way for commercial rollout in its largest markets. This milestone strengthens its position in healthcare technology and opens new sales avenues.

BPH Global is nearing completion of its novel seaweed-based men’s health supplement, Project Popeye, as it moves toward TGA listing and scientific validation.

TALi Digital Limited reported a 116% increase in half-year losses to $570,848 amid the integration of its recent acquisition, You Can Do It! Education. Revenue nearly doubled, reflecting early benefits from the expanded digital health and education platform.

McPherson’s Limited has confirmed a $3.3 million total tax benefit following amended assessments by the ATO, linked to deductible costs from a strategic alliance announced in 2022.

Adrad Holdings reported a modest revenue rise and a dip in statutory profit for the half-year ending December 2025, while its Heat Transfer Solutions segment showed robust growth. The company declared a fully franked interim dividend, reflecting confidence amid ongoing restructuring.

Articore Group Limited reports a significant turnaround in 1HFY26 with improved profitability and margin expansion, prompting an upgrade to its FY26 EBIT guidance. The company’s strategic initiatives in marketing, supply chain, and technology are driving renewed momentum.

Prime Financial Group has reported a robust first half of FY26, with revenue climbing 31% and underlying EBITDA soaring 60%, driven by strategic acquisitions and organic growth.

Autosports Group Limited reported a robust half-year with revenue rising 10.9% to $1.52 billion and profit after tax more than doubling to $21.68 million. The company declared a fully franked interim dividend of 5 cents per share, reflecting confidence in its growth trajectory.

NRW Holdings reported a robust first half of FY26, driven by strong segment performances and the strategic acquisition of Fredon Industries, boosting revenue and profits significantly.

Cogstate Limited reported a solid 12% increase in revenue to $26.9 million for the half-year ended December 2025, driven by growth in its Clinical Trials segment and a 2% rise in net profit before tax. The company’s contracted future Clinical Trials revenue also grew 10%, signalling strong momentum ahead.

Regis Resources Limited has announced a fully franked ordinary dividend of AUD 0.15 per share for the six months ending December 2025, signalling steady returns for shareholders.

Evion Group has secured formal notice from Madagascar’s Mines Ministry that its Maniry Graphite Project permits have passed technical assessment and are set for expedited approval, marking a key step towards production.